Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis

American Journal of Veterinary Research

Volumn 68, Issue 9, 2007, Pages 941-945

  Stewart, Allison A ^a   Byron, Christopher R ^a   Pondenis, Holly ^a   Stewart, Matthew C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; DNA; ELONGATION FACTOR 1ALPHA; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CHONDROGENESIS; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; GENE AMPLIFICATION; HEMATOPOIETIC STEM CELL; HORSE; MESENCHYMAL STEM CELL; MONOLAYER CULTURE; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; TISSUE ENGINEERING; TISSUE REPAIR; TRANSCRIPTION REGULATION; UPREGULATION;

AGGRECANS; ANIMALS; BISBENZIMIDE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; COLLAGEN TYPE II; DNA; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCANS; HISTOCYTOCHEMISTRY; HORSES; MESENCHYMAL STEM CELLS; MICROSCOPY, FLUORESCENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLONIUM CHLORIDE;

ANIMALIA; EQUIDAE;

EID: 34548660408     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.9.941     Document Type: Article

References (32)

1. Jeffcott LB, Rossdale PD, Freestone J. An assessment of wastage in Thoroughbred racing from conception to 4 years of age. Equine Vet J 1982;14:185-198.
2. Pool R, Meager D. Pathologic findings and pathogenesis of racetrack injuries. Vet Clin North Am Equine Pract 1990;6:1-30.
3. Rossdale PD, Hopes R, Digby NJ, et al. Epidemiological study of wastage among racehorses: 1982 and 1983. Vet Rec 1985;116:66-69.
4. Dyson S. Lameness and poor performance in the sports horse: dressage, show jumping and horse trials (eventing), in Proceedings. 46th Annu Meet Am Assoc Equine Pract 2000;46:308-315.
5. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
6. Hunzinker E. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 2002;10:432-463.
7. Chen FH, Rousche KT, Tuan RS. Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2006;2:373-382.
8. Im GI, Jung NH, Tae AK. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng 2006;12:527-536.
9. Solchaga L, Penick K, Porter JD, et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 2005;203:398-409.
10. Worster AA, Brower-Toland B, Fortier L, et al. Chondrogenic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor β-1 in monolayer and insulin-like growth factor-I in a three dimensional matrix. J Orthop Res 2001;19:738-749.
11. Worster AA, Nixon AJ, Brower-Toland B, et al. Effect of transforming growth factor β-1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am J Vet Res 2000;61:1003-1010.
12. Zaragosi LE, Aihaud G, Dani C. Autocrine FGF-2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 2006;24:2412-2419.
13. Levenstein ME, Ludwig TE, Xu RH, et al. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells 2006;24:568-574.
14. Kashiwakura I, Takahashi TA. Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells. Leuk Lymphoma 2005;3:329-333.
15. Kashiwakura I, Takahashi TA. Basic fibroblastic growth factor-stimulated ex-vivo expansion of haematopoietic progenitor cells from human placental and umbilical cord blood. Br J Haematol 2003; 122:479-488.
16. Bianchi G, Banfi A, Mastrogiacomo M, et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003;287:98-105.
17. Martin I, Muraglia A, Campanile G, et al. Fibroblastic growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997;138:4456-4462.
18. Svendsen CN, der Borg MG, Armstrong RJ, et al. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 1998;85:141-152.
19. Kafienah W, Mistry S, Williams C, et al. Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. Stem Cells 2006;24:1113-1120.
20. Hiraki Y, Shukunami C, Iyama K, et al. Differentiation of chondrogenic precursor cells during the regenerative of articular cartilage. Osteoarthritis Cartilage 2001;9(suppl A):S102-S108.
21. Mizuta H, Kudo S, Nakamura E, et al. Active proliferation of mesenchymal cells prior to the chondrogenic repair response in rabbit full-thickness defects of articular cartilage. Osteoarthritis Cartilage 2004;12:586-596.
22. Henson FM, Bowe EA, Davies ME. Promotion of the intrinsic damage-repair response in articular cartilage by fibroblastic growth factor-2. Osteoarthritis Cartilage 2005;13:537-544.
23. Fortier LA, Nixon AJ, Willimas J, et al. Isolation and chondrogenic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 1998;59:1182-1187.
24. Invitrogen Web site. Trypan blue exclusion test of cell viability. Available at: catalog.invitrogen.comindex.cfm?fuseaztion= iprotocol.viewunit&treenodeeid= 9e662cb7ec96e7a4f5acb232240a318a&objective= 675af17c5bd5aa8edfca. Accessed Mar 2, 2007.
25. Kim YJ, Sah RL, Doong JY, et al. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 1988;174:168-176.
26. Johnstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998;238:265-272.
27. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982;9:247-248.
28. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics methods and protocols: methods in molecular biology. Totowa, NJ: Humana Press, 2000;365-386.
29. Sternderup K, Justesen J, Clausen C, et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-926.
30. Zhang H, Fazel S, Tian H, et al. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol 2005;289:H2089-H2096.
31. Okada-Ban M, Thiery JP, Jouanneau J. Molecules in focus: fibroblast growth factor-2. Int J Biochem Cell Biol 2000;32:263-267.
32. Nugent MA, Iozzo RV. Molecules in focus: fibroblast growth factor-2. Int J Biochem Cell Biol 2000;32:115-120.